Indian Immunologicals Ltd rolls out Havisure, India's first indigenous Hepatitis-A vaccine. The two-dose inactivated virus vaccine, developed over eight years, is priced at Rs 2,150 per dose. Extensive clinical trials have shown that Havisure is safe and efficacious for pediatric, adolescent, and adult use.
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/IPjvkZr
Subscribe to:
Post Comments (Atom)
Government concerned over telcos' service quality
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/Oyt4IxX
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
-
The Delhi High Court on Thursday dismissed the pleas of TTV Dhinakaran and VK Sasikala challenging the Election Commission's order grant...
-
Collecting Lego — yes, the plastic toys made of interlocking bricks that become cars and castles and robots —returned more than large stocks...
No comments:
Post a Comment